Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Assets (2023 - 2025)

Historic Assets for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $67.4 million.

  • Connect Biopharma Holdings' Assets changed N/A to $67.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.4 million, marking a year-over-year change of. This contributed to the annual value of $101.3 million for FY2024, which is 2048.36% down from last year.
  • Latest data reveals that Connect Biopharma Holdings reported Assets of $67.4 million as of Q3 2025.
  • In the past 5 years, Connect Biopharma Holdings' Assets registered a high of $144.1 million during Q2 2023, and its lowest value of $67.4 million during Q3 2025.
  • In the last 3 years, Connect Biopharma Holdings' Assets had a median value of $101.3 million in 2024 and averaged $105.2 million.
  • As far as peak fluctuations go, Connect Biopharma Holdings' Assets crashed by 1631.73% in 2024, and later crashed by 3138.84% in 2025.
  • Connect Biopharma Holdings' Assets (Quarter) stood at $127.4 million in 2023, then decreased by 20.48% to $101.3 million in 2024, then tumbled by 33.49% to $67.4 million in 2025.
  • Its Assets was $67.4 million in Q3 2025, compared to $82.7 million in Q2 2025 and $92.7 million in Q1 2025.